New Viatris CEO reiterates commitment to strategic plan

Viatris in November announced that it would be divesting about $9 billion worth of operations while at the same time building out an ophthalmology business.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 9, 2023 Category: Pharmaceuticals Authors: Paul J. Gough Source Type: news